Your browser doesn't support javascript.
loading
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation.
Buttini, Francesca; Hannon, James; Saavedra, Kristi; Rossi, Irene; Balducci, Anna Giulia; Smyth, Hugh; Clark, Andy; Colombo, Paolo.
Afiliación
  • Buttini F; Department of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy.
  • Hannon J; Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, SE19NH, London, UK.
  • Saavedra K; Respira Therapeutics Inc., Albuquerque, New Mexico, USA.
  • Rossi I; Respira Therapeutics Inc., Albuquerque, New Mexico, USA.
  • Balducci AG; Department of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy.
  • Smyth H; Department of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy.
  • Clark A; Chiesi Limited, Bath Road Industrial Estate, Chippenham, Wiltshire, SN14 0AB, UK.
  • Colombo P; Respira Therapeutics Inc., Albuquerque, New Mexico, USA.
Pharm Res ; 33(12): 3012-3020, 2016 12.
Article en En | MEDLINE | ID: mdl-27623625
PURPOSE: In this work, a novel powder dispersion add-on device, the AOS (Axial Oscillating Sphere), was studied in conjunction with commercially available DPI devices to improve the powder dispersion. METHODS: An ordered mixture of formoterol fumarate and lactose was selected. We studied in two laboratories located at different altitudes the dispensing and dispersion of the drug at different flow rates, paying particular attention to a number of metrics of Fine Particle Dose (FPD). RESULTS: Two novel findings emerged from the data collected. First, the aerosol quality, measured as fine particle dose, can be increased by adding the accessory promoting the dispersion and de-aggregation of the formulation. The second finding was that, albeit the emitted dose was independent of altitude, the drug/lactose carrier DPI aerosolizing performance changed with the altitude of testing. In particular, fine particle dose depended on both altitude and device configuration. The RS01 inhaler without the AOS accessory used at higher altitude gave the lowest FPD values. By combining the AOS accessory with the DPI, however, the performance dependence on altitude/atmospheric pressure was essentially removed. CONCLUSIONS: Increasing inhaler performance can be achieved using an add-on accessory that enhances aerosol dispersion and minimizes flow rate dependency.
Asunto(s)
Palabras clave
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhaladores de Polvo Seco Límite: Humans Idioma: En Revista: Pharm Res Año: 2016 Tipo del documento: Article País de afiliación: Italia
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhaladores de Polvo Seco Límite: Humans Idioma: En Revista: Pharm Res Año: 2016 Tipo del documento: Article País de afiliación: Italia